Home LiteratureArticle Details
PMID: 1656084 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication.

Journal of virology ·Vol. 65 ·No. 11 ·1991-11-00 ·Pages 5991-6000

Marchini A, Tomkinson B, Cohen JI, Kieff E

Abstract

The Epstein-Barr virus (EBV) BHRF1 open reading frame is abundantly expressed early in the lytic replication cycle. BHRF1 is also transiently expressed in some latently infected cell lines in the absence of expression of other lytic cycle proteins. BHRF1 shares distant, but significant, colinear primary amino acid sequence homology to Bc12, a cellular gene strongly implicated in the evolution of follicular lymphoma. The experiments reported here used a molecular genetic approach to examine the role of BHRF1 in EBV infection. Isogenic EBV recombinants having either wild-type BHRF1 or a null mutation due to a translational stop signal in place of the 24th BHRF1 codon were used to infect primary B lymphocytes. The BHRF1 mutant recombinants did not differ from the wild type in their ability to infect and transform the growth of primary B lymphocytes, to replicate in the resultant lymphoblastoid cell lines, or to initiate a second round of primary cell transformation. Deletion of the entire BHRF1 open reading frame did not destroy the ability of the mutant virus to maintain cell growth transformation. The significance of these findings with regard to the role of BHRF1 in EBV infection is discussed.

Related Genes
MeSH Terms
B-Lymphocytes/immunology Burkitt Lymphoma Cell Line Chromosome Deletion Gene Expression Regulation, Viral Genes, Viral Herpesvirus 4, Human/genetics,immunology,physiology Humans Lymphocyte Activation Open Reading Frames Plasmids Polymerase Chain Reaction Reference Values Restriction Mapping Sequence Homology, Nucleic Acid Transfection Virus Replication
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Marchini A
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115.
Tomkinson B
Cohen J I
Kieff E
References (60)
60 references, click to expand
  1. Ras C-terminal processing enzymes--new drug targets?
    Cell. 1991 Apr 5;65(1):1-4 PMID: 2013090
  2. Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells.
    J Virol. 1981 May;38(2):632-48 PMID: 6264134
  3. Early events in Epstein-Barr virus infection of human B lymphocytes.
    Virology. 1991 Apr;181(2):595-608 PMID: 1849678
  4. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.
    Nature. 1991 Feb 14;349(6310):612-4 PMID: 1705663
  5. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
    J Virol. 1991 Apr;65(4):1701-9 PMID: 1848303
  6. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    J Virol. 1991 May;65(5):2545-54 PMID: 1850028
  7. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma.
    Nature. 1982 Jan 14;295(5845):160-3 PMID: 6276755
  8. Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells.
    J Virol. 1982 Jul;43(1):262-72 PMID: 6180174
  9. Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcript.
    J Virol. 1983 Oct;48(1):135-48 PMID: 6310141
  10. DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
    Nature. 1984 Jul 19-25;310(5974):207-11 PMID: 6087149
  11. Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection.
    Proc Natl Acad Sci U S A. 1982 Sep;79(18):5698-702 PMID: 6291060
  12. Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.
    J Virol. 1982 Dec;44(3):834-44 PMID: 6294333
  13. Assembly of the mitochondrial membrane system. Structure and nucleotide sequence of the gene coding for subunit 1 of yeast cytochrme oxidase.
    J Biol Chem. 1980 Dec 25;255(24):11927-41 PMID: 6254986
  14. Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants.
    Virology. 1979 Jun;95(2):351-8 PMID: 223286
  15. Complexity of EBV homologous DNA in continous lymphoblastoid cell lines.
    Virology. 1976 Oct 1;74(1):227-31 PMID: 185788
  16. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  17. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.
    Proc Natl Acad Sci U S A. 1972 Feb;69(2):383-7 PMID: 4333982
  18. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
    J Virol. 1976 Jun;18(3):1071-80 PMID: 178913
  19. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
    Biomedicine. 1975 Jul;22(4):276-84 PMID: 179629
  20. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
    Nature. 1990 Nov 22;348(6299):334-6 PMID: 2250705
  21. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase.
    J Virol. 1991 Jul;65(7):3681-92 PMID: 1710288
  22. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
    Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1546-50 PMID: 1847527
  23. DNA replication origin and transcriptional enhancer in c-myc gene share the c-myc protein binding sequences.
    EMBO J. 1989 Dec 20;8(13):4273-9 PMID: 2686984
  24. Structure-independent DNA amplification by PCR using 7-deaza-2'-deoxyguanosine.
    Nucleic Acids Res. 1988 Oct 25;16(20):9869 PMID: 3186456
  25. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
    EMBO J. 1987 Sep;6(9):2743-51 PMID: 2824192
  26. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.
    Proc Natl Acad Sci U S A. 1987 Nov;84(22):8060-4 PMID: 2825176
  27. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 PMID: 2556717
  28. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6 PMID: 3033649
  29. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Nature. 1989 Aug 3;340(6232):393-7 PMID: 2547164
  30. Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells.
    Proc Natl Acad Sci U S A. 1989 Jun;86(12):4589-93 PMID: 2543982
  31. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.
    Cell. 1989 Apr 7;57(1):79-88 PMID: 2649247
  32. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.
    Cell. 1986 Oct 10;47(1):19-28 PMID: 2875799
  33. The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts.
    J Virol. 1988 Jul;62(7):2337-46 PMID: 2836616
  34. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.
    J Virol. 1988 Jul;62(7):2274-84 PMID: 2836611
  35. Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes.
    Proc Natl Acad Sci U S A. 1988 Jun;85(11):3678-82 PMID: 2836854
  36. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus.
    Oncogene. 1988 May;2(5):461-7 PMID: 2836780
  37. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.
    Virology. 1987 Sep;160(1):151-61 PMID: 2820125
  38. Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.
    J Virol. 1987 Dec;61(12):3672-9 PMID: 2824806
  39. Oncogenic potential of bcl-2 demonstrated by gene transfer.
    Nature. 1988 Nov 17;336(6196):259-61 PMID: 2848196
  40. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.
    Cell. 1988 Nov 4;55(3):427-33 PMID: 2846181
  41. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.
    J Virol. 1988 Nov;62(11):4173-84 PMID: 2845129
  42. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.
    Cell. 1985 Dec;43(3 Pt 2):831-40 PMID: 3000618
  43. Isolation and characterization of cDNA clones corresponding to transcripts from the BamHI H and F regions of the Epstein-Barr virus genome.
    J Virol. 1987 Sep;61(9):2902-9 PMID: 3039177
  44. The BamHI F region of the B95-8 Epstein-Barr virus genome.
    Virology. 1985 Nov;147(1):99-109 PMID: 2998075
  45. Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H.
    J Virol. 1985 Aug;55(2):286-97 PMID: 2991556
  46. Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells.
    Proc Natl Acad Sci U S A. 1989 Mar;86(6):1958-62 PMID: 2538824
  47. Elevated recombination rates in transcriptionally active DNA.
    Cell. 1989 Feb 24;56(4):619-30 PMID: 2645056
  48. Mechanism of antigen-driven selection in germinal centres.
    Nature. 1989 Dec 21-28;342(6252):929-31 PMID: 2594086
  49. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Nature. 1988 Sep 29;335(6189):440-2 PMID: 3262202
  50. Polyoma virus DNA replication requires an enhancer.
    Nature. 1984 Nov 15-21;312(5991):242-6 PMID: 6095089
  51. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.
    Cell. 1986 Jan 31;44(2):283-92 PMID: 3943125
  52. Protein kinase activity associated with a cell cycle regulated, membrane-bound Epstein-Barr virus induced early antigen.
    Intervirology. 1990;31(1):1-13 PMID: 2159954
  53. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
    J Virol. 1990 Jun;64(6):2530-6 PMID: 2159528
  54. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    J Virol. 1990 Jul;64(7):3407-16 PMID: 2352328
  55. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    J Virol. 1990 May;64(5):2309-18 PMID: 2157887
  56. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.
    J Immunol. 1990 May 1;144(9):3602-10 PMID: 2184193
  57. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    J Virol. 1990 Mar;64(3):1002-13 PMID: 2154588
  58. Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphocytes.
    J Virol. 1990 Apr;64(4):1667-74 PMID: 2157049
  59. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.
    J Virol. 1990 May;64(5):2319-26 PMID: 2157888
  60. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
    Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6343-7 PMID: 1648738
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1991-11-00
Pages
5991-6000
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC250264
Subset
IM
Grants
NCI NIH HHS · CA47006 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]